Q & A with Tom Reeves, President and CEO of Interface Biologics. Interface has successfully grown through the stages from Bench, to Start Up, to clinical Market Leader. Find out how they did it!
Back to All Events
Earlier Event: October 23
Great Governance for Growth
Later Event: November 29
OBIO EXECUTIVE EXCHANGE SERIES: OPTIMIZING CLINICAL STATEGIES TO DRIVE REIMBURSEMENT